Nu Ride (NRDE) director reports December stock purchases and 763,000-share stake
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Nu Ride Inc. reported insider share purchases by a director in December 2025. The reporting person bought 16,787 shares of common stock on 12/16/2025 at $1.41 per share and 23,213 shares on 12/17/2025 at $1.48 per share. After these transactions, the director directly beneficially owned 763,000 Nu Ride common shares. The filing notes that the reporting person and Andrew L. Sole disclaim beneficial ownership of these securities except to the extent of their pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 40,000 shares ($58,025)
Net Buy
2 txns
Insider
ESOPUS CREEK VALUE SERIES FUND LP - SERIES A
Role
Director
Bought
40,000 shs ($58K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock, par value $0.0001 | 23,213 | $1.48 | $34K |
| Purchase | Common Stock, par value $0.0001 | 16,787 | $1.41 | $24K |
Holdings After Transaction:
Common Stock, par value $0.0001 — 763,000 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider stock transactions did Nu Ride (NRDE) report in December 2025?
A Nu Ride Inc. director reported purchasing 16,787 common shares on 12/16/2025 at $1.41 and 23,213 shares on 12/17/2025 at $1.48.
What prices were paid for Nu Ride (NRDE) common stock in the insider purchases?
The director paid $1.41 per share for 16,787 shares on 12/16/2025 and $1.48 per share for 23,213 shares on 12/17/2025.
What is the relationship of the reporting person to Nu Ride Inc. (NRDE)?
The reporting person is identified as a director of Nu Ride Inc., as indicated in the relationship section of the report.
Who signed the insider trading report for Nu Ride (NRDE)?
The report was signed by /s/ Andrew L. Sole, described as managing member of Esopus Creek Advisors, LLC, general partner of Esopus Creek Value Series Fund LP - Series A.